Wheaton College, USA.
Am J Bioeth. 2011 Apr;11(4):31-40. doi: 10.1080/15265161.2011.560339.
When in 2006 the Centers for Disease Control and Prevention issued revised recommendations for HIV testing in health care settings, vocal opponents charged that use of an "opt-out" approach to presenting HIV testing to patients; the implementation of nontargeted, widespread HIV screening; the elimination of a separate signed consent; and the decoupling of required HIV prevention counseling from HIV testing are unethical. Here we undertake the first systematic ethical examination of the arguments both for and against the recommendations. Our examination reveals that the ethical concerns raised by the critics predominantly pertain not to ethically suspect elements of the recommendations themselves, but to suspicions that they will be implemented improperly. It has not been shown that the recommendations cannot be implemented properly. Here we show that in the United States the recommendations are morally justifiable and that safeguards or regulatory oversight may serve to ensure that the recommendations are properly implemented.
当 2006 年疾病控制与预防中心发布了医疗环境中 HIV 检测的修订建议时,一些强烈反对的声音指控说,向患者提出 HIV 检测时采用“默认同意”的方法;实施非针对性的、广泛的 HIV 筛查;取消单独的书面同意;以及将 HIV 预防咨询与 HIV 检测脱钩,这些做法是不道德的。在这里,我们首次对支持和反对这些建议的论点进行了系统的伦理审查。我们的审查表明,批评者提出的伦理问题主要不是针对建议本身有道德问题的方面,而是对他们怀疑这些建议将被不当实施的问题。目前还没有证据表明这些建议不能得到妥善执行。在这里,我们表明,在美国,这些建议在道德上是合理的,并且可以采取保障措施或监管监督来确保这些建议得到妥善执行。